Scarica l'app Stockscreener
13.26
3.51%
0.45
Pre-mercato:
13.18
-0.08
-0.60%
Intellia Therapeutics Inc Azioni (NTLA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
67.01%
23.02
|
13.78 | 14.24 | 16.63 | 9.111 |
Operating Expenses
|
2.82%
121.73
|
125.26 | 124.24 | 137.43 | 153.88 |
| Benefits Costs and Expenses |
5.15%
118.80
|
125.26 | 124.24 | 130.96 | 153.88 |
| Costs And Expenses |
2.82%
121.73
|
125.26 | 124.24 | 137.43 | 153.88 |
| Operating Income/Loss |
11.45%
-98.71
|
-111.48 | -110.00 | -120.81 | -144.77 |
| Income/Loss From Continuing Operations Before Tax |
14.08%
-95.79
|
-111.48 | -101.25 | -114.33 | -144.77 |
| Income/Loss From Continuing Operations After Tax |
5.47%
-95.79
|
-101.32 | -101.25 | -114.33 | -135.71 |
|
Net Income/Loss
|
5.47%
-95.79
|
-101.32 | -101.25 | -114.33 | -135.71 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
97.70%
2.535
|
110.19 | 103.73 | 103.50 | 101.00 |
| Diluted Average Shares |
97.70%
2.535
|
110.19 | 103.73 | 103.50 | 101.00 |
| Basic Earnings Per Share |
10.87%
-0.82
|
-0.92 | -0.98 | -1.10 | -1.34 |
| Diluted Earnings Per Share |
10.87%
-0.82
|
-0.92 | -0.98 | -1.10 | -1.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):